This cluster of papers explores the role of Urotensin II in cardiovascular physiology and disease, focusing on its vasoconstrictor activity, impact on hypertension, atherosclerosis, endothelial dysfunction, and renal function. It also discusses the development of receptor antagonists and its involvement in smooth muscle cell proliferation and the neuroendocrine system.